Your browser doesn't support javascript.
loading
C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple-negative breast cancer.
Liao, Li; Deng, Ling; Zhang, Yin-Ling; Yang, Shao-Ying; Andriani, Lisa; Hu, Shu-Yuan; Zhang, Fang-Lin; Shao, Zhi-Min; Li, Da-Qiang.
Afiliación
  • Liao L; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Deng L; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang YL; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yang SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Andriani L; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu SY; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhang FL; Cancer Institute, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shao ZM; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li DQ; Department of Breast Surgery, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China.
Clin Transl Med ; 13(11): e1480, 2023 11.
Article en En | MEDLINE | ID: mdl-38009308

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Clin Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Animals / Humans Idioma: En Revista: Clin Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China